LeserbriefKommentar
Comment on “Valuation of EQ-5D-5L Health States in Poland: The First EQ-VT-Based Study in Central and Eastern Europe”
PharmacoEconomics · 06.11.2026
DOI: 10.1007/s40273-026-01684-3 ↗Kurz gefasst
Leserbrief in der Zeitschrift PharmacoEconomics, online erschienen am 06.11.2026. Verfasst von Peter Wilson. Beteiligte Einrichtung: Stryker Corporation, Portage, MI, USA. pywils@gmail.com. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Stryker Corporation, Portage, MI, USA. pywils@gmail.com.
Zitieren
APA
Wilson, P. (2026). Comment on “Valuation of EQ-5D-5L Health States in Poland: The First EQ-VT-Based Study in Central and Eastern Europe”. PharmacoEconomics. https://doi.org/10.1007/s40273-026-01684-3
Vancouver
Wilson P. Comment on “Valuation of EQ-5D-5L Health States in Poland: The First EQ-VT-Based Study in Central and Eastern Europe”. PharmacoEconomics. 2026. doi:10.1007/s40273-026-01684-3
BibTeX
@article{Wilson2026,
author = {Wilson, Peter},
title = {Comment on “Valuation of EQ-5D-5L Health States in Poland: The First EQ-VT-Based Study in Central and Eastern Europe”},
journal = {PharmacoEconomics},
year = {2026},
doi = {10.1007/s40273-026-01684-3}
}
EUVIMED